Basic Information
Landmark Bio is a developer of a bioplatform aimed at bridging the gap between breakthrough cell and gene therapy research and clinical applications. The company's platform provides technologies and expertise from academic and life science industry leaders, along with a collaborative platform that enables researchers, physician-scientists, and biopharmaceutical leaders to accelerate the development of transformative therapies.
Landmark Bio, PBLLC
Massachusetts,United States of America
15~50 people
January 01, 2021
info@landmarkbio.com

